According to the report of the Korea Central Epidemic Prevention Countermeasure Headquarters on the 23rd, on the 22nd, South Korea added There were 171,452 confirmed cases of new coronary pneumonia, an increase of more than 70,000 from the 21st, and a total of 2,329,182 confirmed cases. In this regard, a South Korean government official said on the 23rd that “it can be seen as a positive signal to return to daily life.”
According to Yonhap News Agency on the 23rd, Sun Yinglai, head of the strategy team of the Central Emergency Response Headquarters, said at a routine press conference that day that in the short term, the diagnosis of The sudden increase in the number of people will lead to an increase in the absolute number of critically ill patients and deaths, and an increase in risk. However, the new coronavirus strain currently spreading in South Korean society is Omicron, whose mortality rate is significantly lower than that of Delta. Therefore, from a medium and long-term perspective, it can be regarded as a positive signal for returning to daily life. On the 22nd, the South Korean government stated that it is currently in the early stage of the new crown virus gradually becoming an “endemic epidemic”.
The Korea Food and Drug Safety Administration approved the inclusion of the “Comirnaty 0.1mg” new crown vaccine in the list of imported drugs on the 23rd, for use in South Korea for 5-11 years old Population vaccination. The vaccine was developed by Pfizer in the United States to prevent children aged 5-11 from contracting new coronary pneumonia.
Source: Global Times
Special correspondent of this newspaper Kim Hye-jin